$Hims & Hers Health(HIMS.US) | Canaccord ๐ฟ๐ฒ๐ถ๐๐ฒ๐ฟ๐ฎ๐๐ฒ๐ ๐๐๐ on ๐๐ถ๐บ๐ & ๐๐ฒ๐ฟ๐ ๐๐ฒ๐ฎ๐น๐๐ต, maintains PT at $๐ฐ๐ฌ
Analyst sees strong Q2 results and momentum in newer specialties, international markets, and AI supporting the reiterated Buy.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments